Edition:
India

Dicerna Pharmaceuticals Inc (DRNA.OQ)

DRNA.OQ on NASDAQ Stock Exchange Global Select Market

9.44USD
22 Nov 2017
Change (% chg)

$-0.40 (-4.07%)
Prev Close
$9.84
Open
$9.89
Day's High
$9.89
Day's Low
$9.26
Volume
60,282
Avg. Vol
47,052
52-wk High
$10.24
52-wk Low
$2.43

Latest Key Developments (Source: Significant Developments)

Dicerna Pharmaceuticals Q3 loss per share ‍$0.92
Friday, 3 Nov 2017 

Nov 2 (Reuters) - Dicerna Pharmaceuticals Inc :Q3 2017 loss per share ‍$0.92.  Full Article

Boehringer, Dicerna collaborate to develop novel treatments for chronic liver diseases including nonalcoholic steatohepatitis
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Dicerna Pharmaceuticals Inc :Boehringer Ingelheim and Dicerna announce collaboration to develop novel treatments for chronic liver diseases including nonalcoholic steatohepatitis (NASH).Dicerna Pharmaceuticals Inc - ‍under terms of agreement, Dicerna may receive more than $200 million from Boehringer Ingelheim​.Dicerna Pharmaceuticals Inc - ‍Dicerna is also eligible to receive royalties staggered up to double-digits on worldwide net sales​.  Full Article

Dicerna files clinical trial application for DCR-PHXC for phase 1 study in hyperoxaluria
Monday, 16 Oct 2017 

Oct 16 (Reuters) - Dicerna Pharmaceuticals Inc : :Dicerna files clinical trial application for DCR-PHXC, the company’s most advanced GalXC™ product candidate, for phase 1 study in primary hyperoxaluria (ph).Dicerna Pharmaceuticals Inc - ‍company expects to initiate clinical dosing in Q1 2018​.Dicerna Pharmaceuticals Inc - ‍company plans to submit additional CTAS in other European countries later this year​.  Full Article

Dicerna Pharmaceuticals files for mixed shelf of up to $150 million
Thursday, 13 Oct 2016 

Dicerna Pharmaceuticals Inc :Files for mixed shelf of up to $150 million - SEC filing.  Full Article

Dicerna reports Q2 2016 financial results
Friday, 5 Aug 2016 

Dicerna Pharmaceuticals Inc : Dicerna reports second quarter 2016 financial and operational results . Reiterates its expectation that it has sufficient cash to fund operations for at least next 12 months ; qtrly loss per share $0.75 .Q2 earnings per share view $-0.84 -- Thomson Reuters I/B/E/S.  Full Article

Dicerna Qtrly loss per share $0.76
Tuesday, 10 May 2016 

Dicerna Pharmaceuticals Inc : Qtrly loss per share $0.76 . Q1 earnings per share view $-0.86 -- Thomson Reuters I/B/E/S .Dicerna reports first quarter 2016 financial and operational results.  Full Article

Dicerna Pharmaceuticals announces appointment of John "Jack" Green as Chief Financial Officer
Tuesday, 19 Apr 2016 

Dicerna Pharmaceuticals:Appointment of John B. "Jack" Green as chief financial officer (CFO), effective immediately.  Full Article

BRIEF-Dicerna Pharmaceuticals Q3 loss per share ‍$0.92

* Q3 2017 loss per share ‍$0.92 Source text for Eikon: Further company coverage: